July 2018 Update
Northgate Medical Practice is research active Practice.
We are currently taking part in National Institute for Health Research (NIHR) portfolio and other high quality research studies. Research is part of NHS work, giving patients better access to the possible benefits research brings. Last year, over 600,000 NHS patients chose to take part in clinical research. Thanks to those patients, we are learning more all the time about how to deal with a whole range of medication conditions that will improve lives.
During your visit you may be invited to take part in one of the research studies we are running or we may have written to you to tell you about a research study you might be interested in taking part in.
You will always receive clear information about what taking part in a research study would involve. You will have the opportunity to ask questions and obtain further details about a study.
You are under no obligation to participate in any research project. Your care and your relationship with your doctor or nurse will not be affected in any way if you decided not to take part in a research study.
By taking part in these studies, we hope to help improve care for our patients in the future.
In line with the new GDPR regulations coming into force on 25th May, we wanted to update all patients with clear information about how we are using your data with respect to research. For more information, please pick up a leaflet in surgery, for more information or contact Nichola Love (Nichola.firstname.lastname@example.org or the practice team).
Website fair processing - research Northgate.docx
Studies running at Northgate Medical Practice in the coming months:
CLASP 4 study - Renewed Online Feasibility Study. Cancer: Life Affirming Survivorship support in Primary care (CLASP) Programme
There is a need for tailored support for cancer survivors, to improve their quality of life. This study will assess an online intervention, called Renewed Online, that offers lifestyle and wellbeing support for cancer survivors.
We will be sending information to survivors of Breast, Prostate and Colorectal Cancer to seek anyone who may be interested in taking part.
This study aims to identify reasons why patients with type 2 diabetes might respond well or poorly to particular drugs. The way patients respond to treatment based on their particular characteristics such as weight or kidney function, will enable better targeting of treatment for a particular individual.